Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Vidhi Specialty Food Ingredients Limited (VIDHIING.NS)
Mumbai, IN
Vidhi Specialty Food Ingredients Limited, headquartered in Mumbai, India, was established in 1994. The company primarily specializes in the manufacturing and supply of synthetic food colors, while also engaging in the trade of various chemicals. Its comprehensive product range includes synthetic water-soluble colors, aluminum lakes, and both FD&C and D&C certified colors and lakes. Additionally, Vidhi provides natural colors, natural lakes, and iron oxide-based pigments. These diverse coloring solutions are utilized extensively across numerous sectors, such as the food and beverage industry, confectionery, pharmaceuticals, animal feed, cosmetics, inkjet inks, and specialized salt-free color applications. Beyond its core food ingredient operations, the company also sources and exports non-food dyes, a category that includes acid, textile, reactive, and basic dyes, as well as various pigments. Vidhi Specialty Food Ingredients boasts a significant international presence, serving markets throughout Asia, Europe, South Africa, the Middle East, and the United States, among other global regions. The company, initially incorporated as Vidhi Dyestuffs Manufacturing Limited, officially changed its name to Vidhi Specialty Food Ingredients Limited in August 2016.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.37% | -5.99% | -8.48% | -5.67% | -20.57% | -15.81% | -34.21% | -17.02% | +44.85% | +387.44% | +392.35% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%-0.6% Q1'26: +12.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+12.8% Q1'26: +10.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.7% Q1'26: +25.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+18.1% ★ Q1'26: +15.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.0% ★ Q1'26: +15.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.74× Q1'26: 0.70× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.85B
est: 2.19B (-15.7%)
|
1.87B
est: 1.90B (-2.0%)
|
2.05B
est: 2.17B (-5.4%)
|
2.22B
est: 2.32B (-4.5%)
|
2.13B
est: 2.56B (-16.5%)
|
2.60B
est: 2.84B (-8.5%)
|
5.27B
est: 3.27B (+61.3%)
|
3.96B
est: 3.76B (+5.4%)
|
2.19B
2.19B – 2.19B
-41.7% YoY
|
1.90B
1.90B – 1.90B
-13.1% YoY
|
2.17B
2.17B – 2.17B
+14.0% YoY
|
2.32B
2.32B – 2.32B
+7.0% YoY
|
2.56B
2.56B – 2.56B
+10.1% YoY
|
2.84B
2.84B – 2.84B
+11.0% YoY
|
| EBITDA |
256.77M
est: 385.66M (-33.4%)
|
290.49M
est: 335.12M (-13.3%)
|
309.96M
est: 382.18M (-18.9%)
|
459.42M
est: 408.94M (+12.3%)
|
503.92M
est: 401.71M (+25.4%)
|
533.02M
est: 499.98M (+6.6%)
|
847.11M
est: 577.51M (+46.7%)
|
556.30M
est: 665.61M (-16.4%)
|
385.66M
385.66M – 385.66M
-42.1% YoY
|
335.12M
335.12M – 335.12M
-13.1% YoY
|
382.18M
382.18M – 382.18M
+14.0% YoY
|
408.94M
408.94M – 408.94M
+7.0% YoY
|
450.44M
450.44M – 450.44M
+10.1% YoY
|
499.98M
499.98M – 499.98M
+11.0% YoY
|
| EBIT |
235.16M
est: 356.21M (-34.0%)
|
267.90M
est: 309.53M (-13.4%)
|
285.01M
est: 336.49M (-15.3%)
|
435.59M
est: 377.71M (+15.3%)
|
474.26M
est: 416.04M (+14.0%)
|
503.78M
est: 461.80M (+9.1%)
|
815.97M
est: 524.50M (+55.6%)
|
519.35M
est: 604.51M (-14.1%)
|
356.21M
356.21M – 356.21M
-41.1% YoY
|
309.53M
309.53M – 309.53M
-13.1% YoY
|
353.00M
353.00M – 353.00M
+14.0% YoY
|
377.71M
377.71M – 377.71M
+7.0% YoY
|
416.04M
416.04M – 416.04M
+10.1% YoY
|
461.80M
461.80M – 461.80M
+11.0% YoY
|
| Net Income |
147.32M
est: 146.28M (+0.7%)
|
146.54M
est: 164.26M (-10.8%)
|
156.32M
est: 157.27M (-0.6%)
|
290.55M
est: 265.61M (+9.4%)
|
339.21M
est: 330.51M (+2.6%)
|
365.59M
est: 369.45M (-1.0%)
|
585.68M
est: 433.27M (+35.2%)
|
377.00M
est: 499.37M (-24.5%)
|
146.28M
146.28M – 146.28M
-70.7% YoY
|
164.26M
164.26M – 164.26M
+12.3% YoY
|
157.27M
157.27M – 157.27M
-4.3% YoY
|
265.61M
265.61M – 265.61M
+68.9% YoY
|
330.51M
330.51M – 330.51M
+24.4% YoY
|
369.45M
369.45M – 369.45M
+11.8% YoY
|
| SGA |
22.98M
est: 122.11M (-81.2%)
|
68.17M
est: 106.11M (-35.8%)
|
97.95M
est: 121.01M (-19.1%)
|
111.35M
est: 129.48M (-14.0%)
|
128.38M
est: 142.62M (-10.0%)
|
121.78M
est: 158.31M (-23.1%)
|
214.33M
est: 492.02M (-56.4%)
|
226.47M
est: 210.67M (+7.5%)
|
122.11M
122.11M – 122.11M
-42.0% YoY
|
106.11M
106.11M – 106.11M
-13.1% YoY
|
121.01M
121.01M – 121.01M
+14.0% YoY
|
129.48M
129.48M – 129.48M
+7.0% YoY
|
142.62M
142.62M – 142.62M
+10.1% YoY
|
158.31M
158.31M – 158.31M
+11.0% YoY
|
| EPS |
2.95
est: 2.93 (+0.7%)
|
2.93
est: 3.29 (-10.9%)
|
3.13
est: 3.15 (-0.6%)
|
5.82
est: 5.32 (+9.4%)
|
6.79
est: 6.62 (+2.6%)
|
7.32
est: 7.40 (-1.1%)
|
11.75
est: 11.99 (-2.0%)
|
7.55
est: 19.42 (-61.1%)
|
2.93
2.93 – 2.93
-84.9% YoY
|
3.29
3.29 – 3.29
+12.3% YoY
|
3.15
3.15 – 3.15
-4.3% YoY
|
5.32
5.32 – 5.32
+68.9% YoY
|
6.62
6.62 – 6.62
+24.4% YoY
|
7.40
7.40 – 7.40
+11.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mihir Bipin Manek | Joint MD & Executive Director | 33M | male |
| Bipin Madhavji Manek | Executive Chairman & MD | 33M | male |
| Vidhi Harsh Parekh | Executive Whole-time Director | 1M | female |
| Manoj Madhukar Jadhav | Senior R&D Officer | — | — |
| Anupam Jitendra Vyas | Company Secretary & Compliance Officer | — | male |
| Mitesh Dinesh Manek | Chief Financial Officer | — | male |
| Nilesh S. Khedekar | Marketing Manager | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VIDHIING.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
